{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:41:47Z","timestamp":1772790107202,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["endocrinologydiabetes.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Endocrinology and Diabetes"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.aed.2025.09.013","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:59:14Z","timestamp":1759348754000},"page":"37-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment of Refractory Syndrome of Inappropriate Antidiuresis With Sodium-Glucose Cotransporter-2 Inhibitor"],"prefix":"10.1016","volume":"13","author":[{"given":"Nicole","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4197-5344","authenticated-orcid":false,"given":"Aidar R.","family":"Gosmanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.aed.2025.09.013_bib1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1210\/endrev\/bnad010","article-title":"Syndrome of inappropriate antidiuresis: from pathophysiology to management","volume":"44","author":"Warren","year":"2023","journal-title":"Endocr Rev"},{"issue":"9","key":"10.1016\/j.aed.2025.09.013_bib2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/jclinpath-2014-202243","article-title":"The syndrome of inappropriate antidiuresis is associated with excess long-term mortality: a retrospective cohort analyses","volume":"67","author":"Basu","year":"2014","journal-title":"J Clin Pathol"},{"issue":"11","key":"10.1016\/j.aed.2025.09.013_bib3","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1210\/clinem\/dgaa547","article-title":"Risk of adverse clinical outcomes in hyponatremic adult patients hospitalized for acute medical conditions: a population-based cohort study","volume":"105","author":"Kutz","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.aed.2025.09.013_bib4","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa619","article-title":"Fluid restriction therapy for chronic SIAD; results of a prospective randomized controlled trial","volume":"105","author":"Garrahy","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.aed.2025.09.013_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/j.ajkd.2019.11.012","article-title":"Efficacy of furosemide, oral sodium chloride, and fluid restriction for treatment of syndrome of inappropriate antidiuresis (SIAD): an open-label randomized controlled study (the EFFUSE-FLUID trial)","volume":"76","author":"Krisanapan","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.aed.2025.09.013_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.40313","article-title":"Use of urea for the syndrome of inappropriate secretion of antidiuretic hormone: a systematic review","volume":"6","author":"Wendt","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.aed.2025.09.013_bib7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2019090944","article-title":"A randomized trial of empagliflozin to increase plasma sodium levels in patients with the syndrome of inappropriate antidiuresis","volume":"31","author":"Refardt","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.aed.2025.09.013_bib8","doi-asserted-by":"crossref","first-page":"894","DOI":"10.4158\/EP12130.OR","article-title":"Hypothyroidism as a cause of hyponatremia: fact or fiction?","volume":"18","author":"Sun","year":"2012","journal-title":"Endocr Pract"},{"key":"10.1016\/j.aed.2025.09.013_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231180983","article-title":"Is there a causal relationship between hypothyroidism and hyponatremia?","volume":"14","author":"Chen","year":"2023","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.aed.2025.09.013_bib10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41574-025-01138-4","article-title":"Hyponatraemia in ageing","volume":"21","author":"Monnerat","year":"2025","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.aed.2025.09.013_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41594-023-01134-0","article-title":"Transport and inhibition mechanism of the human SGLT2-MAP17 glucose transporter","volume":"31","author":"Hiraizumi","year":"2024","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"10.1016\/j.aed.2025.09.013_bib12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1681\/ASN.2022050623","article-title":"Treatment effect of the SGLT2 inhibitor empagliflozin on chronic syndrome of inappropriate antidiuresis: results of a randomized, double-blind, placebo-controlled, crossover trial","volume":"34","author":"Refardt","year":"2023","journal-title":"J Am Soc Nephrol"}],"container-title":["AACE Endocrinology and Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050915725001262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050915725001262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:29:56Z","timestamp":1768868996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050915725001262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S3050915725001262"],"URL":"https:\/\/doi.org\/10.1016\/j.aed.2025.09.013","relation":{},"ISSN":["3050-9157"],"issn-type":[{"value":"3050-9157","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Refractory Syndrome of Inappropriate Antidiuresis With Sodium-Glucose Cotransporter-2 Inhibitor","name":"articletitle","label":"Article Title"},{"value":"AACE Endocrinology and Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aed.2025.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the AACE.","name":"copyright","label":"Copyright"}]}}